Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period

Journal of Infection and Chemotherapy

Volumn 20, Issue 7, 2014, Pages 423-428

  Okade, Hayato ^a,b   Funatsu, Tori ^b   Eto, Maki ^b   Furuya, Yuri ^a,b   Mizunaga, Shingo ^b   Nomura, Nobuhiko ^b   Mitsuyama, Junichi ^b   Yamagishi, Yuka ^c   Mikamo, Hiroshige ^a,c  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

^c AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Non invasive pneumococcal disease; PCV7; Streptococcus pneumoniae

Indexed keywords

BACTERIAL VACCINE; BETA LACTAM DERIVATIVE; CARBAPENEM DERIVATIVE; CEPHEM DERIVATIVE; MACROLIDE; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; VACCINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; CELLULAR DISTRIBUTION; CHILD; CHILDHOOD DISEASE; ERM(B) GENE; GENE; GENETIC CODE; GENETIC SUSCEPTIBILITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MEF(A) GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE MUCUS; PNEUMOCOCCAL INFECTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE; CLASSIFICATION; DRUG EFFECTS; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; NEWBORN; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PROCEDURES; SEROTYPE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MACROLIDES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84903701262     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.03.010     Document Type: Article

References (22)

1. Mitchell AM, Mitchell TJ. Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect 2010;16: 411-8.
2. Song JH, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012;30: 2728-37.
3. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and consideration for future conjugate vaccines. Int J Infect Dis 2010;14:e197-209.
4. Grijalva CG, Pelton SI. A second generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr 2011;23: 98-104.
5. Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 2012;12:207.
6. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Hance LF, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;7:e1000348.
7. Pillai DR, Shahinas D, Buzina A, Pollock RA, Lau R, Khairnar K, et al. Genomewide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009;10:642.
8. Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Laxau C, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008;197: 1016-27.
9. Revai K, McCormick DP, Patel J, Grady JJ, Saeed K, Chonmaitree T. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics 2006;117: 1823-9.
10. Chiba N, Morozumi M, Shouji M, Wajima T, Iwata S, Sunakawa K, et al. Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan. Microb Drug Resist 2013;19(4): 308-15.
11. Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, Komori T, et al. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 2010;138: 61-8.
12. Tanaka J, Ishiwada N, Wada A, Chang B, Hishiki H, Kurosaki T, et al. Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan. Epidemiol Infect 2012;140: 1111-21.
13. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M07-A8. Wayne: Clinical and Laboratory Standards Institute; 2009.
14. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. twenty-third information supplement. M100eS23. Wayne: Clinical and Laboratory Standards Institute; 2013.
15. Matsui N, Ito M, Kuramae H, Inukai T, Sakai A, Okugawa M. Infective endocarditis caused by multidrug-resistant Streptococcus mitis in a combined immunocompromised patient: an autopsy case report. J Infect Chemother 2013;19: 321-5.
16. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2005;40: 1738-44.
17. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotype 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008;47: 1388-95.
18. Alonso M, Marimon JM, Ercibengoa M, Prez-Yarza EG, Perez-Trallero E. Dynamics of Streptococcus pneumoniae serotyes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12- year period (1999-2010) in a region of northern Spain. PLoS One 2013;8:e54333.
19. Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotype of Streptococcus pneumoniae isolated in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012;56: 1418-26.
20. Cho EY, Kang HM, Lee J, Kang JH, Choi EH, Lee HJ. Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine. J Korean Med Sci 2012;27: 716-22.
21. Otsuka T, Kitami O, Kondo K, Ota H, Oshima S, Tsuchiya A, et al. Incidence survey of acute otitis media in children in Sado island, Japan-Sado Otitis Media Study (SADOMS). PLoS One 2013;8:e68711.
22. Eto M, Mizunaga S, Fukuda Y, Nomura N, Mitsuyama J, Yamaoka J, et al. Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefecture (2010-2011). Jpn J Antibiot 2013;66: 265-83.